This content is machine translated Gastrointestinal stromal tumors Portrait of a multifaceted disease With the introduction of the new active ingredient avapritinib for the targeted treatment of gastrointestinal stromal tumors into the German market, this clinical picture is once again coming more into…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
View Post 2 min This content is machine translated Gastrointestinal stromal tumors (GIST) Is the survival prognosis actually worse for GIST of the small bowel? GIST is most commonly found in the stomach and small intestine. A new comprehensive analysis of the U.S. Surveillance, Epidemiology, and End Results (SEER) database shows that, contrary to popular…
View Post 2 min This content is machine translated 10 years GIST Group Switzerland GIST – a life with cancer Since 2004, the patient organization “GIST Group Switzerland” (www.gist.ch) has been supporting patients with gastrointestinal stromal tumors (GIST) and their families. This year’s annual meeting offered a special program for…
